Your session is about to expire
← Back to Search
CBD Oil for Stress Related to COVID-19 (CBDOIL Trial)
CBDOIL Trial Summary
This trial will compare the effects of CBD isolate, full-spectrum CBD oil, broad-spectrum CBD oil, and placebo oil on reducing stress caused by COVID-19.
CBDOIL Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.CBDOIL Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are willing to complete a brief pre-study 7-day online symptom monitoring log.You are fluent in English.\nYou are allergic to coconut oil.You have tried to harm yourself in the last six months.You agree not to use any CBD products that are not provided by the study during the 6-week study period.You have experienced negative effects from using CBD oil or other CBD products in the past.You must avoid using any non-study CBD products during the 6-week study period.
- Group 1: Broad-Spectrum CBD oil 300 mg.
- Group 2: Placebo Oil
- Group 3: Full-Spectrum CBD Oil 300 mg.
- Group 4: CBD-Isolate 300 mg.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are patients still being enrolled in this research project?
"Yes, as the clinicaltrials.gov website shows, this trial is still seeking patients. The listing was originally posted on December 4th, 2020 and was last edited on June 2nd, 2022."
Can people of all ages participate in this research?
"This study includes all patients that fall within the age parameters of 18 to 70 years old."
To whom does this research opportunity extend?
"This study is looking for 160 participants who currently suffer from anger. The patients must also meet the following criteria: Displays elevated symptom scores on one or more of the following established assessment instruments for depression (PROMIS-Depression), anxiety (PROMIS-Anxiety), Anger (PROMIS-Anger), sleep disturbance (PROMIS-Sleep); or Alcohol/Substance (PROMIS-Alcohol; PROMIS- Substance Use), Age between 18 to 70;, Fluent in English;, Has home access to the Internet;, Willingness to provide signed informed consent;"
How many total people are allowed to join this clinical trial?
"That is accurate. According to the information available on clinicaltrials.gov, this study is still looking for patients. It was first posted on 2020-12-04 and was updated on 2022-06-02. The research team hopes to enroll 160 patients from 1 medical facility."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Texas at Austin, Laboratory for the Study of Anxiety Disorders: < 48 hours
Average response time
- < 2 Days
Share this study with friends
Copy Link
Messenger